Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TMCITMCI
20 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in TREACE MED CONCEPTS INC

CITADEL ADVISORS LLC holds 825,575 shares of TMCI (TREACE MED CONCEPTS INC), worth $1.1M as of 2026-Q1. The position was increased (+289.6% shares). TMCI represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$1.1M

Current Shares

825,575

Total Value Change

-$2.1M

Total Shares Change

+722,334

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
825,575
+289.6%
$1.1M0.0%$1.57
41
2025-Q4
New
211,906
-
$519,1700.0%$2.48
33
2025-Q3
Exited
0
-100.0%
$00.0%$6.72
0
2025-Q2
Decreased
59,230
-78.2%
$348,2720.0%$5.75
0
2025-Q1
Increased
271,272
+3.6%
$2.3M0.0%$8.45
27
2024-Q4
Increased
261,770
+271.1%
$1.9M0.0%$6.88
42
2024-Q3
Decreased
70,540
-85.7%
$409,1320.0%$5.77
0
2024-Q2
Increased
491,874
+667.1%
$3.3M0.0%$6.65
43
2024-Q1
Decreased
64,119
-51.9%
$836,7530.0%$13.05
0
2023-Q4
Increased
133,294
+5.8%
$1.7M0.0%$12.75
27
2023-Q3
Increased
125,957
+98.7%
$1.7M0.0%$13.11
41
2023-Q2
Decreased
63,386
-88.7%
$1.6M0.0%$24.67
0
2023-Q1
Increased
562,112
+57.6%
$14.2M0.0%$25.72
40
2022-Q4
Increased
356,638
+132.5%
$8.2M0.0%$22.99
44
2022-Q3
Increased
153,422
+141.0%
$3.4M0.0%$22.74
43
2022-Q2
Decreased
63,670
-39.5%
$913,0000.0%$14.42
0
2022-Q1
Increased
105,316
+50.0%
$2M0.0%$18.92
36
2021-Q4
Decreased
70,199
-45.6%
$1.3M0.0%$18.52
0
2021-Q3
Increased
129,093
+25.0%
$3.5M0.0%$27.50
33
2021-Q2
New
103,241
-
$3.2M0.0%$30.48
37

Other major holders of TMCI: CIBC Bancorp USA Inc., CIBC Private Wealth Group LLC, ALLIANCEBERNSTEIN L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used